1. Home
  2. PULM vs MOGO Comparison

PULM vs MOGO Comparison

Compare PULM & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • MOGO
  • Stock Information
  • Founded
  • PULM 2003
  • MOGO 2003
  • Country
  • PULM United States
  • MOGO Canada
  • Employees
  • PULM N/A
  • MOGO N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • PULM Health Care
  • MOGO
  • Exchange
  • PULM Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • PULM 28.3M
  • MOGO 25.1M
  • IPO Year
  • PULM N/A
  • MOGO N/A
  • Fundamental
  • Price
  • PULM $8.90
  • MOGO $1.39
  • Analyst Decision
  • PULM
  • MOGO Strong Buy
  • Analyst Count
  • PULM 0
  • MOGO 1
  • Target Price
  • PULM N/A
  • MOGO $4.00
  • AVG Volume (30 Days)
  • PULM 20.6K
  • MOGO 7.2M
  • Earning Date
  • PULM 05-15-2025
  • MOGO 05-08-2025
  • Dividend Yield
  • PULM N/A
  • MOGO N/A
  • EPS Growth
  • PULM N/A
  • MOGO N/A
  • EPS
  • PULM N/A
  • MOGO N/A
  • Revenue
  • PULM $1,921,000.00
  • MOGO $28,873,274.00
  • Revenue This Year
  • PULM N/A
  • MOGO $59.16
  • Revenue Next Year
  • PULM $134.88
  • MOGO $6.17
  • P/E Ratio
  • PULM N/A
  • MOGO N/A
  • Revenue Growth
  • PULM N/A
  • MOGO 0.62
  • 52 Week Low
  • PULM $1.78
  • MOGO $0.74
  • 52 Week High
  • PULM $10.40
  • MOGO $2.73
  • Technical
  • Relative Strength Index (RSI)
  • PULM 69.72
  • MOGO 58.23
  • Support Level
  • PULM $7.94
  • MOGO $1.20
  • Resistance Level
  • PULM $9.37
  • MOGO $1.63
  • Average True Range (ATR)
  • PULM 0.66
  • MOGO 0.25
  • MACD
  • PULM 0.30
  • MOGO 0.00
  • Stochastic Oscillator
  • PULM 88.69
  • MOGO 23.25

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: